FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, ...

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

A separate study by Oxford University, published in Lancet's eClinicalMedicine journal, analyzed more than 100 million U.S. medical records and found that Ozempic users experienced lower rates of ...

Memory loss might have met its match. A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing ...

Ozempic May Lower Dementia Risk in People With Type 2 Diabetes, Study Finds Add this to the growing list of potential perks of the drug. By Korin Miller Published: Jul 18, 2024 7:30 AM EDT ...

The case for Ozempic as a dementia buster is building. Research published this week has found that GLP-1 drugs are associated with a lower risk of dementia in people with type 2 diabetes.

Well, this is just one study, so it’s hard to say for sure that Ozempic will lower your risk for dementia. But a 2024 study published in the journal Alzheimer’s & Dementia also linked these ...

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what to know, per a neurologist.